Literature DB >> 8771637

The at-risk health status and technology: a diagnostic invitation and the 'gift' of knowing.

R H Kenen1.   

Abstract

In the past two decades, the medical model has extended its jurisdiction to cover a new medical entity-the at-risk health status-which is frequently accompanied by what I call a diagnostic invitation and the 'gift' of knowing. In cases, however, where the diagnosis may only reaffirm the risk but can provide no cure, the value of the 'gift' of knowing is questioned. The at-risk health status also can: (1) develop a symbiotic relationship with diagnostic technology, (2) become an organizing principle in individual and social behavior and (3) provide new tasks for clinical medicine. The perceived cost effectiveness of preventive measures, combined with the desire to use high-technology medicine, to achieve newly expanded definitions of health make it likely that the concept of the at-risk health status will be integrated into whatever health care plan is finally enacted for the United States. In light of the possible negative, as well as positive, effects of at-risk health labelling, American society needs to establish standards for the diagnostic invitation as a gift of knowing especially when the line between prevention and overuse is not always clear.

Entities:  

Mesh:

Year:  1996        PMID: 8771637     DOI: 10.1016/0277-9536(95)00248-0

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  14 in total

1.  Exploring adoption with clients: the need for adoption education within the genetic counseling profession.

Authors:  Cassandra L Perry; Martha J Henry
Journal:  J Genet Couns       Date:  2010-03-16       Impact factor: 2.537

2.  Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.

Authors:  Christine M Gunn; Barbara G Bokhour; Victoria A Parker; Tracy A Battaglia; Patricia A Parker; Angela Fagerlin; Worta McCaskill-Stevens; Hanna Bandos; Sarah B Blakeslee; Christine Holmberg
Journal:  Med Decis Making       Date:  2019-02-25       Impact factor: 2.583

3.  Genetic counseling for the next 25 years: Models for the future.

Authors:  R H Kenen; A C Smith
Journal:  J Genet Couns       Date:  1995-06       Impact factor: 2.537

4.  Being 'at-risk' for developing cancer: cognitive representations and psychological outcomes.

Authors:  Shoshana Shiloh; Erga Drori; Avi Orr-Urtreger; Eitan Friedman
Journal:  J Behav Med       Date:  2008-09-19

5.  Negotiating responsibility: case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease.

Authors:  Claudia Downing
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

6.  The ethics of type 1 diabetes prediction and prevention research.

Authors:  Lainie Friedman Ross
Journal:  Theor Med Bioeth       Date:  2003

7.  Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.

Authors:  Emily E Anderson; Kent Hoskins
Journal:  J Health Care Poor Underserved       Date:  2012-11

8.  Rethinking scientific responsibility.

Authors:  Annika Forssén; Eivind Meland; Irene Hetlevik; Roger Strand
Journal:  J Med Ethics       Date:  2011-01-25       Impact factor: 2.903

9.  Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.

Authors:  Maria Caiata-Zufferey; Olivia Pagani; Viviane Cina; Véronique Membrez; Monica Taborelli; Sheila Unger; Anne Murphy; Christian Monnerat; Pierre O Chappuis
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

10.  Women's experiences receiving abnormal prenatal chromosomal microarray testing results.

Authors:  Barbara A Bernhardt; Danielle Soucier; Karen Hanson; Melissa S Savage; Laird Jackson; Ronald J Wapner
Journal:  Genet Med       Date:  2012-09-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.